Reperfusion therapy is the primary treatment for which ACS type?

Reperfusion therapy is the primary treatment for which ACS type?

• A. NSTEMI
• B. STEMI
• C. Unstable Angina
• D. Stable Angina

Answer: (B)

Restoring blood flow quickly to a fully blocked coronary artery is essential when there is complete occlusion causing ST-segment elevations. This situation is ST-elevation myocardial infarction, where the heart muscle is at immediate risk of extensive damage if flow isn’t reopened promptly. Because the occlusion is complete, the primary treatment is reperfusion therapy—opening the artery as soon as possible with urgent percutaneous coronary intervention (PCI) or, when PCI isn’t available quickly, thrombolytic therapy to restore flow. In contrast, other ACS types don’t involve a complete blockage with ST elevation. NSTEMI involves partial occlusion and typically does not require immediate reperfusion with thrombolytics; the focus is on antiplatelet and anticoagulant therapy and planning for early invasive evaluation and possible PCI. Unstable angina shares a similar urgency pattern without myocardial necrosis at presentation, so management centers on stabilizing the patient and assessing coronary revascularization as needed rather than emergent reperfusion. Stable angina is not an acute infarct and is managed with long-term anti-ischemic and risk-reduction strategies, not immediate reperfusion. So, reperfusion therapy as the primary treatment is best associated with STEMI, where rapid restoration of blood flow minimizes myocardial damage.

Restoring blood flow quickly to a fully blocked coronary artery is essential when there is complete occlusion causing ST-segment elevations. This situation is ST-elevation myocardial infarction, where the heart muscle is at immediate risk of extensive damage if flow isn’t reopened promptly. Because the occlusion is complete, the primary treatment is reperfusion therapy—opening the artery as soon as possible with urgent percutaneous coronary intervention (PCI) or, when PCI isn’t available quickly, thrombolytic therapy to restore flow.

In contrast, other ACS types don’t involve a complete blockage with ST elevation. NSTEMI involves partial occlusion and typically does not require immediate reperfusion with thrombolytics; the focus is on antiplatelet and anticoagulant therapy and planning for early invasive evaluation and possible PCI. Unstable angina shares a similar urgency pattern without myocardial necrosis at presentation, so management centers on stabilizing the patient and assessing coronary revascularization as needed rather than emergent reperfusion. Stable angina is not an acute infarct and is managed with long-term anti-ischemic and risk-reduction strategies, not immediate reperfusion.

So, reperfusion therapy as the primary treatment is best associated with STEMI, where rapid restoration of blood flow minimizes myocardial damage.